PAZOPANIB

PAZOPANIB was reported 26971 times

PAZOPANIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DESMOPLASTIC SMALL ROUND CELL TUMOUR 36 0.4138
1 ALVEOLAR SOFT PART SARCOMA METASTATIC 2 0.3333
2 EXTRASKELETAL MYXOID CHONDROSARCOMA 3 0.2727
3 SYNOVIAL SARCOMA METASTATIC 6 0.2500
4 POORLY DIFFERENTIATED THYROID CARCINOMA 2 0.2000
5 CARDIAC VENTRICULAR SCARRING 3 0.2000
6 PLEOMORPHIC LIPOSARCOMA 2 0.1818
7 SOLITARY FIBROUS TUMOUR 3 0.1765
8 OSTEOSARCOMA METASTATIC 15 0.1579
9 GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL INCREASED 2 0.1538
10 EPITHELIOID SARCOMA 4 0.1290
11 NEUROFIBROSARCOMA 13 0.1262
12 CHONDROSARCOMA METASTATIC 3 0.1111
13 LEIOMYOSARCOMA METASTATIC 7 0.1029
14 PERIPHERAL NERVE SHEATH TUMOUR MALIGNANT 3 0.1000
15 ALVEOLAR RHABDOMYOSARCOMA 4 0.0909
16 SALIVARY DUCT INFLAMMATION 2 0.0870
17 LYMPHANGIECTASIA INTESTINAL 4 0.0800
18 SKIN ANGIOSARCOMA 2 0.0769
19 CEMENTOPLASTY 2 0.0625
20 ENDOMETRIAL STROMAL SARCOMA 3 0.0600
21 ANGIOSARCOMA METASTATIC 7 0.0574
22 TUMOUR CAVITATION 3 0.0545
23 PELVIC SEPSIS 2 0.0541
24 ALVEOLAR SOFT PART SARCOMA 2 0.0541
25 DEDIFFERENTIATED LIPOSARCOMA 2 0.0500
26 GAIT APRAXIA 2 0.0488
27 CONCOMITANT DRUG EFFECT DECREASED 2 0.0465
28 SARCOMA METASTATIC 6 0.0432
29 ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA 2 0.0417
30 RENAL CELL CARCINOMA RECURRENT 5 0.0394
31 RENAL ADENOMA 2 0.0392
32 RETROPERITONEAL CANCER 3 0.0375
33 UTERINE LEIOMYOSARCOMA 3 0.0375
34 MALIGNANT NEOPLASM OF PLEURA 4 0.0325
35 SECONDARY CEREBELLAR DEGENERATION 2 0.0323
36 SYNOVIAL SARCOMA 3 0.0316
37 TP53 GENE MUTATION 3 0.0309
38 LEUKOERYTHROBLASTOSIS 3 0.0300
39 CARDIAC NEOPLASM MALIGNANT 2 0.0282
40 CLEAR CELL RENAL CELL CARCINOMA 18 0.0259
41 PHYLLODES TUMOUR 2 0.0247
42 SPINDLE CELL SARCOMA 3 0.0221
43 PLATELET TOXICITY 2 0.0217
44 SERRATIA TEST POSITIVE 2 0.0206
45 HEREDITARY HAEMORRHAGIC TELANGIECTASIA 2 0.0204
46 METASTASES TO THORAX 5 0.0198
47 ANGIOSARCOMA 9 0.0195
48 CHORDOMA 2 0.0194
49 SMALL INTESTINE CARCINOMA METASTATIC 2 0.0192
50 HEPATOBILIARY DISEASE 12 0.0192
51 BENIGN BONE NEOPLASM 4 0.0191
52 DESMOID TUMOUR 4 0.0190
53 CHONDROSARCOMA 3 0.0190
54 ACUTE PULMONARY HISTOPLASMOSIS 3 0.0189
55 LEIOMYOSARCOMA 7 0.0182
56 SOFT TISSUE SARCOMA 6 0.0172
57 METASTATIC RENAL CELL CARCINOMA 31 0.0169
58 OSTEOSARCOMA 6 0.0156
59 SARCOMA UTERUS 2 0.0155
60 METASTASES TO SOFT TISSUE 4 0.0154
61 VENTRICULAR DYSKINESIA 3 0.0144
62 METASTASES TO PELVIS 9 0.0142
63 METASTASES TO ABDOMINAL CAVITY 7 0.0142
64 ADENOMATOUS POLYPOSIS COLI 2 0.0142
65 PARAGANGLION NEOPLASM 2 0.0137
66 RENAL CANCER RECURRENT 2 0.0136
67 PHARYNGOTONSILLITIS 3 0.0133
68 METASTASES TO ADRENALS 12 0.0130
69 METASTASES TO KIDNEY 7 0.0127
70 AORTIC VALVE THICKENING 2 0.0124
71 METASTASES TO RETROPERITONEUM 2 0.0118
72 PULMONARY NECROSIS 4 0.0117
73 INTERLEUKIN-2 RECEPTOR INCREASED 2 0.0117
74 METASTASES TO CHEST WALL 4 0.0115
75 PERICARDIAL EFFUSION MALIGNANT 2 0.0112
76 METASTASES TO PERITONEUM 28 0.0111
77 HYPERADRENOCORTICISM 3 0.0109
78 RECALL PHENOMENON 9 0.0108
79 SCLERAL DISCOLOURATION 7 0.0107
80 PULMONARY HILUM MASS 2 0.0106
81 RHABDOMYOSARCOMA 2 0.0106
82 METASTASES TO PLEURA 11 0.0105
83 TUMOUR NECROSIS 11 0.0104
84 RENAL CANCER METASTATIC 8 0.0104
85 PROLACTIN-PRODUCING PITUITARY TUMOUR 2 0.0102
86 PERINEAL INFECTION 2 0.0101
87 METASTASES TO ABDOMINAL WALL 2 0.0101
88 METASTASES TO HEART 3 0.0099
89 BRONCHIAL FISTULA 2 0.0099
90 ACOUSTIC NEUROMA 4 0.0098
91 METASTASES TO THE MEDIASTINUM 4 0.0097
92 BRAIN NATRIURETIC PEPTIDE ABNORMAL 2 0.0093
93 IRON BINDING CAPACITY TOTAL DECREASED 2 0.0090
94 METASTASES TO PANCREAS 4 0.0090
95 PARANEOPLASTIC SYNDROME 6 0.0089
96 PNEUMOTHORAX SPONTANEOUS 6 0.0088
97 BLOOD CHROMOGRANIN A INCREASED 4 0.0087
98 METASTASES TO LUNG 100 0.0086
99 BILIARY SEPSIS 4 0.0086
100 ENDOTHELIAL DYSFUNCTION 2 0.0086
101 RENAL CELL CARCINOMA 42 0.0086
102 ECZEMA ASTEATOTIC 4 0.0085
103 AUTOIMMUNE HYPOTHYROIDISM 2 0.0084
104 CHRONIC LEFT VENTRICULAR FAILURE 3 0.0083
105 JEJUNAL PERFORATION 2 0.0083
106 GASTROINTESTINAL STROMAL TUMOUR 21 0.0079
107 EYE COLOUR CHANGE 8 0.0079
108 TUMOUR PAIN 10 0.0076
109 ILEAL PERFORATION 5 0.0075
110 ATRIAL ENLARGEMENT 2 0.0074
111 TUMOUR RUPTURE 4 0.0071
112 THYROID CANCER 85 0.0071
113 REGRESSIVE BEHAVIOUR 2 0.0069
114 RETINOPATHY HYPERTENSIVE 2 0.0066
115 CONTRAINDICATION TO MEDICAL TREATMENT 10 0.0065
116 SARCOMA 7 0.0062
117 TUMOUR INVASION 3 0.0062
118 METASTASES TO LYMPH NODES 41 0.0061
119 PROTEIN-LOSING GASTROENTEROPATHY 3 0.0060
120 SOFT TISSUE NECROSIS 4 0.0058
121 FUNGAL TEST POSITIVE 2 0.0057
122 INTESTINAL METASTASIS 2 0.0055
123 VENA CAVA THROMBOSIS 9 0.0054
124 FAECES PALE 12 0.0054
125 MALIGNANT PLEURAL EFFUSION 9 0.0053
126 BRONCHOPLEURAL FISTULA 2 0.0053
127 LACRIMAL STRUCTURE INJURY 2 0.0053
128 FEMALE GENITAL TRACT FISTULA 9 0.0053
129 MALIGNANT NEOPLASM PROGRESSION 517 0.0050
130 ADRENAL ADENOMA 3 0.0050
131 HEPATORENAL FAILURE 3 0.0050
132 PANCREAS INFECTION 2 0.0050
133 ADENOCARCINOMA 11 0.0049
134 HAIR COLOUR CHANGES 61 0.0049
135 URETEROLITHIASIS 5 0.0048
136 LYMPHADENOPATHY MEDIASTINAL 9 0.0047
137 PERITONEAL DISORDER 3 0.0046
138 ENTEROCUTANEOUS FISTULA 4 0.0045
139 PNEUMATOSIS 2 0.0045
140 METASTASES TO SPINE 15 0.0045
141 OESOPHAGITIS ULCERATIVE 3 0.0044
142 POLYCYTHAEMIA 9 0.0044
143 BODY MASS INDEX DECREASED 2 0.0043
144 DEVICE RELATED THROMBOSIS 4 0.0041
145 PNEUMOTHORAX 64 0.0040
146 JAUNDICE CHOLESTATIC 14 0.0040
147 SKIN HYPOPIGMENTATION 7 0.0040
148 SPLENIC HAEMORRHAGE 2 0.0039
149 AORTIC VALVE CALCIFICATION 2 0.0039
150 NEOPLASM RECURRENCE 13 0.0038
151 PRODUCT INEFFECTIVE 3 0.0038
152 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 3 0.0038
153 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 36 0.0038
154 LEFT VENTRICULAR DYSFUNCTION 25 0.0037
155 ANAL ULCER 3 0.0037
156 SKIN DEPIGMENTATION 5 0.0037
157 AMYLASE INCREASED 13 0.0035
158 RADIATION NECROSIS 2 0.0035
159 GASTROINTESTINAL FISTULA 3 0.0034
160 HEPATOTOXICITY 76 0.0034
161 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 79 0.0034
162 MALIGNANT PERITONEAL NEOPLASM 2 0.0034
163 HYPERTENSIVE ENCEPHALOPATHY 2 0.0034
164 BILE DUCT STENOSIS 4 0.0033
165 GASTROINTESTINAL TOXICITY 16 0.0033
166 METASTASES TO LIVER 57 0.0032
167 BLOOD OSMOLARITY DECREASED 2 0.0032
168 INTRACRANIAL MASS 3 0.0032
169 ELECTROCARDIOGRAM CHANGE 3 0.0032
170 NEUTROPENIC INFECTION 3 0.0031
171 NEPHROTIC SYNDROME 21 0.0031
172 METASTASES TO CENTRAL NERVOUS SYSTEM 39 0.0030
173 PERFORMANCE STATUS DECREASED 14 0.0030
174 PROTEINURIA 57 0.0030
175 IMMUNE-MEDIATED HEPATITIS 6 0.0029
176 OSTEOLYSIS 6 0.0029
177 DUODENITIS 9 0.0029
178 COMPUTERISED TOMOGRAM THORAX ABNORMAL 2 0.0029
179 RENAL MASS 6 0.0029
180 ANASTOMOTIC LEAK 2 0.0029
181 METASTASES TO BONE 47 0.0029
182 CONTRAINDICATED DRUG ADMINISTERED 2 0.0029
183 PANCREATIC MASS 3 0.0028
184 VENTRICULAR HYPOKINESIA 9 0.0028
185 CALCULUS URETERIC 2 0.0028
186 HAEMORRHAGIC DISORDER 3 0.0028
187 ARRHYTHMIA SUPRAVENTRICULAR 3 0.0027
188 CARDIAC DYSFUNCTION 10 0.0027
189 THYROIDITIS 8 0.0027
190 BLOOD BILIRUBIN INCREASED 71 0.0026
191 SPINAL CORD COMPRESSION 10 0.0026
192 METASTASIS 18 0.0025
193 EMBOLISM ARTERIAL 3 0.0025
194 BONE LESION 9 0.0025
195 CARDIOTOXICITY 22 0.0025
196 TUMOUR HAEMORRHAGE 7 0.0025
197 PERITONSILLAR ABSCESS 2 0.0024
198 HEPATORENAL SYNDROME 4 0.0024
199 WOUND DEHISCENCE 8 0.0024
200 NEOPLASM PROGRESSION 82 0.0024
201 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
202 GLIOBLASTOMA 4 0.0023
203 BLOOD BILIRUBIN ABNORMAL 3 0.0023
204 COLONIC ABSCESS 2 0.0023
205 BLOOD AMYLASE INCREASED 4 0.0023
206 OBSTRUCTION GASTRIC 3 0.0023
207 ACUTE CORONARY SYNDROME 19 0.0023
208 HEPATIC FUNCTION ABNORMAL 84 0.0022
209 INTRA-ABDOMINAL FLUID COLLECTION 4 0.0022
210 HYPOTHYROIDISM 71 0.0022
211 DISEASE PROGRESSION 263 0.0022
212 ALANINE AMINOTRANSFERASE INCREASED 136 0.0022
213 PROTEIN URINE 2 0.0022
214 ASCITES 65 0.0022
215 ARTERIOVENOUS MALFORMATION 2 0.0022
216 ANEURYSM RUPTURED 2 0.0022
217 THERAPY PARTIAL RESPONDER 34 0.0022
218 MICROANGIOPATHY 2 0.0021
219 TRANSAMINASES INCREASED 47 0.0021
220 CARDIAC TAMPONADE 10 0.0021
221 CEREBELLAR HAEMORRHAGE 3 0.0021
222 LIPASE INCREASED 16 0.0021
223 HEPATIC LESION 9 0.0021
224 HEPATIC MASS 4 0.0021
225 ARTERIAL THROMBOSIS 4 0.0021
226 BICYTOPENIA 4 0.0020
227 HYPERBILIRUBINAEMIA 21 0.0020
228 CELL DEATH 4 0.0020
229 CHOLANGIOCARCINOMA 3 0.0020
230 MUCOSAL DISORDER 2 0.0020
231 HAEMATOTOXICITY 19 0.0020
232 MUCOSAL INFLAMMATION 52 0.0020
233 AUTONOMIC NEUROPATHY 2 0.0020
234 BRAIN STEM INFARCTION 2 0.0020
235 CANCER PAIN 5 0.0020
236 CARDIAC FAILURE ACUTE 13 0.0019
237 HYPERURICAEMIA 8 0.0019
238 MULTIPLE-DRUG RESISTANCE 6 0.0019
239 TUMOUR LYSIS SYNDROME 17 0.0019
240 BRONCHIAL DISORDER 3 0.0019
241 SUBILEUS 4 0.0019
242 VENTRICULAR ARRHYTHMIA 7 0.0019
243 HYPOPERFUSION 2 0.0019
244 INTERMITTENT CLAUDICATION 3 0.0019
245 HYPERTENSIVE CRISIS 21 0.0019
246 HYPERPHOSPHATAEMIA 4 0.0019
247 BLOOD THYROID STIMULATING HORMONE INCREASED 17 0.0018
248 ACINETOBACTER INFECTION 2 0.0018
249 HEPATITIS CHOLESTATIC 11 0.0018
250 OCULAR TOXICITY 2 0.0018
251 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 2 0.0018
252 SUDDEN CARDIAC DEATH 6 0.0018
253 PNEUMATOSIS INTESTINALIS 5 0.0018
254 AUTOIMMUNE HAEMOLYTIC ANAEMIA 6 0.0017
255 INFECTION REACTIVATION 2 0.0017
256 DIFFUSE ALVEOLAR DAMAGE 2 0.0017
257 HYPERAMMONAEMIC ENCEPHALOPATHY 3 0.0017
258 HYPERTRANSAMINASAEMIA 12 0.0017
259 PAROTITIS 2 0.0017
260 BILIRUBIN CONJUGATED INCREASED 4 0.0017
261 HYPOCHLORAEMIA 2 0.0017
262 PROCALCITONIN INCREASED 2 0.0017
263 FEBRILE INFECTION 2 0.0017
264 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3 0.0017
265 INTESTINAL PERFORATION 19 0.0017
266 BONE MARROW DISORDER 5 0.0017
267 ASPARTATE AMINOTRANSFERASE INCREASED 86 0.0016
268 NECROSIS 9 0.0016
269 EJECTION FRACTION DECREASED 25 0.0016
270 SMALL INTESTINAL PERFORATION 3 0.0016
271 BILE DUCT OBSTRUCTION 3 0.0016
272 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
273 BLOOD ALKALINE PHOSPHATASE INCREASED 39 0.0016
274 RHEUMATIC DISORDER 3 0.0016
275 CONCOMITANT DISEASE PROGRESSION 3 0.0015
276 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34 0.0015
277 ANAL FISTULA 8 0.0015
278 STEATORRHOEA 4 0.0015
279 JAUNDICE 40 0.0015
280 GLYCOSURIA 2 0.0015
281 ABDOMINAL RIGIDITY 4 0.0015
282 AORTIC DISSECTION 6 0.0014
283 ILEUS 18 0.0014
284 GASTROINTESTINAL PERFORATION 6 0.0014
285 SECOND PRIMARY MALIGNANCY 12 0.0014
286 LARGE INTESTINE PERFORATION 10 0.0014
287 CARDIOMYOPATHY 21 0.0014
288 INTESTINAL FISTULA 2 0.0014
289 ALVEOLITIS 2 0.0014
290 PULMONARY MASS 21 0.0014
291 METASTATIC NEOPLASM 6 0.0014
292 PRODUCT USE IN UNAPPROVED INDICATION 343 0.0014
293 RENAL INFARCT 2 0.0014
294 HYPERTHYROIDISM 20 0.0014
295 PATHOLOGICAL FRACTURE 7 0.0014
296 HYPERCALCAEMIA 17 0.0014
297 THROMBOCYTOSIS 5 0.0014
298 ACUTE ABDOMEN 2 0.0014
299 PARESIS 3 0.0013
300 GASTROINTESTINAL WALL THICKENING 2 0.0013
301 BLOOD LACTIC ACID INCREASED 7 0.0013
302 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
303 METASTASES TO MENINGES 3 0.0013
304 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
305 PLEURAL EFFUSION 79 0.0013
306 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
307 THROMBOCYTOPENIA 142 0.0013
308 URINARY TRACT OBSTRUCTION 3 0.0013
309 ENTERITIS 8 0.0012
310 PNEUMONITIS 34 0.0012
311 BLOOD DISORDER 10 0.0012
312 GASTROINTESTINAL OBSTRUCTION 3 0.0012
313 DRUG-INDUCED LIVER INJURY 39 0.0012
314 SKIN TOXICITY 7 0.0012
315 HEPATIC NEOPLASM 4 0.0012
316 GLOMERULONEPHRITIS 3 0.0012
317 OSTEONECROSIS OF JAW 30 0.0012
318 EMBOLISM 10 0.0012
319 PROTEIN URINE PRESENT 6 0.0012
320 SKIN WOUND 2 0.0012
321 FLANK PAIN 11 0.0012
322 LUNG NEOPLASM 5 0.0012
323 HEPATOSPLENOMEGALY 3 0.0012
324 AORTIC ARTERIOSCLEROSIS 3 0.0012
325 AMYLOIDOSIS 2 0.0012
326 VIITH NERVE PARALYSIS 4 0.0012
327 VENTRICULAR DYSFUNCTION 3 0.0012
328 DERMATITIS ACNEIFORM 7 0.0011
329 LUNG OPACITY 3 0.0011
330 FOOD INTERACTION 2 0.0011
331 ABDOMINAL ABSCESS 5 0.0011
332 FEBRILE NEUTROPENIA 75 0.0011
333 JUGULAR VEIN THROMBOSIS 2 0.0011
334 ABDOMINAL MASS 3 0.0011
335 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
336 SOFT TISSUE INFECTION 2 0.0011
337 LUNG CONSOLIDATION 3 0.0011
338 LIVER FUNCTION TEST INCREASED 23 0.0011
339 PSYCHOMOTOR RETARDATION 3 0.0011
340 LIVER FUNCTION TEST ABNORMAL 31 0.0011
341 IMMUNE THROMBOCYTOPENIC PURPURA 3 0.0011
342 PERICARDIAL EFFUSION 24 0.0010
343 IMMUNE-MEDIATED HEPATIC DISORDER 2 0.0010
344 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
345 VENOUS THROMBOSIS 4 0.0010
346 GENE MUTATION 2 0.0010
347 EMPYEMA 2 0.0010
348 AZOTAEMIA 4 0.0010
349 CORONARY ARTERY STENOSIS 5 0.0010
350 EMBOLISM VENOUS 3 0.0010
351 REBOUND EFFECT 11 0.0010
352 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
353 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
354 HAEMOPTYSIS 27 0.0010
355 SKIN NECROSIS 5 0.0010
356 THYROID FUNCTION TEST ABNORMAL 4 0.0010
357 HEPATIC FAILURE 29 0.0010
358 MYOCARDITIS 11 0.0010
359 ATRIAL TACHYCARDIA 2 0.0010
360 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
361 SLEEP DEFICIT 2 0.0009
362 BILE DUCT STONE 3 0.0009
363 RENAL NEOPLASM 2 0.0009
364 FEBRILE BONE MARROW APLASIA 4 0.0009
365 PROCTALGIA 6 0.0009
366 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
367 PYELONEPHRITIS 8 0.0009
368 PARONYCHIA 4 0.0009
369 ENDOMETRIAL CANCER 2 0.0009
370 OTITIS MEDIA 3 0.0009
371 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
372 HYPERTENSION 191 0.0009
373 CHOLESTATIC LIVER INJURY 2 0.0009
374 MALIGNANT MELANOMA 12 0.0009
375 MYOSITIS 8 0.0009
376 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
377 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
378 HYPERGLYCAEMIA 32 0.0009
379 HAEMATURIA 30 0.0009
380 BRAIN NEOPLASM 8 0.0009
381 RETINAL DETACHMENT 8 0.0009
382 HAEMORRHAGE INTRACRANIAL 13 0.0009
383 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
384 NEUTROPENIA 116 0.0009
385 DUODENAL ULCER 6 0.0008
386 CHOLECYSTITIS 10 0.0008
387 BONE MARROW FAILURE 17 0.0008
388 FAECAL INCONTINENCE 4 0.0008
389 PLATELET COUNT ABNORMAL 5 0.0008
390 THROMBOTIC MICROANGIOPATHY 8 0.0008
391 CARDIOMEGALY 10 0.0008
392 BLOOD CREATININE INCREASED 53 0.0008
393 RETINAL TEAR 2 0.0008
394 PIGMENTATION DISORDER 5 0.0008
395 HEPATIC ENZYME ABNORMAL 4 0.0008
396 TROPONIN INCREASED 6 0.0008
397 PULMONARY EMBOLISM 74 0.0008
398 PHYSICAL DECONDITIONING 2 0.0008
399 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
400 HEPATOCELLULAR INJURY 11 0.0008
401 ELECTROLYTE IMBALANCE 9 0.0008
402 LIVER INJURY 19 0.0008
403 HYPOALBUMINAEMIA 6 0.0008
404 CARDIOPULMONARY FAILURE 3 0.0008
405 GENERAL PHYSICAL HEALTH DETERIORATION 89 0.0008
406 HEPATITIS TOXIC 2 0.0008
407 PULMONARY HAEMORRHAGE 6 0.0008
408 WOUND SECRETION 3 0.0008
409 ANAEMIA 144 0.0008
410 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
411 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
412 DEHYDRATION 99 0.0007
413 ANAL ABSCESS 4 0.0007
414 HYPOCALCAEMIA 14 0.0007
415 RENAL IMPAIRMENT 62 0.0007
416 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
417 HYPONATRAEMIA 41 0.0007
418 DECREASED APPETITE 169 0.0007
419 CONGESTIVE CARDIOMYOPATHY 3 0.0007
420 PROCTITIS 2 0.0007
421 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
422 PLATELET COUNT DECREASED 75 0.0007
423 OESOPHAGEAL STENOSIS 2 0.0007
424 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
425 DUODENAL ULCER HAEMORRHAGE 2 0.0007
426 EXERCISE TOLERANCE DECREASED 4 0.0007
427 MULTI-ORGAN FAILURE 12 0.0007
428 BLOOD URIC ACID INCREASED 4 0.0007
429 DYSPNOEA AT REST 2 0.0007
430 HEPATIC ENZYME INCREASED 47 0.0007
431 HAEMOTHORAX 2 0.0007
432 STRESS CARDIOMYOPATHY 4 0.0007
433 DRUG LEVEL DECREASED 7 0.0007
434 CARDIAC FAILURE 55 0.0007
435 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
436 MENTAL STATUS CHANGES 19 0.0007
437 HYPERTRIGLYCERIDAEMIA 4 0.0007
438 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
439 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
440 HEPATITIS FULMINANT 2 0.0007
441 BACTERAEMIA 8 0.0007
442 RHABDOMYOLYSIS 28 0.0007
443 BRAIN HERNIATION 2 0.0007
444 PROTHROMBIN TIME PROLONGED 4 0.0007
445 HYDRONEPHROSIS 5 0.0007
446 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
447 HEPATITIS B 4 0.0007
448 SUDDEN DEATH 7 0.0007
449 COLITIS 25 0.0007
450 ADRENAL INSUFFICIENCY 8 0.0007
451 CHEST X-RAY ABNORMAL 2 0.0007
452 FIBROSIS 2 0.0006
453 SMALL INTESTINAL OBSTRUCTION 8 0.0006
454 BRAIN DEATH 2 0.0006
455 MUSCULOSKELETAL CHEST PAIN 10 0.0006
456 CHOLANGITIS 4 0.0006
457 LUNG INFECTION 10 0.0006
458 ERYTHEMA MULTIFORME 6 0.0006
459 RENAL CYST 5 0.0006
460 ORTHOPNOEA 2 0.0006
461 ATRIAL FLUTTER 5 0.0006
462 HEPATITIS 16 0.0006
463 PANCREATITIS ACUTE 14 0.0006
464 DRUG RESISTANCE 16 0.0006
465 SKIN EROSION 2 0.0006
466 CHROMATURIA 14 0.0006
467 SKIN ULCER 16 0.0006
468 RESPIRATORY FAILURE 45 0.0006
469 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
470 DRUG INTERACTION 97 0.0006
471 MYELOSUPPRESSION 22 0.0006
472 STOMATITIS 37 0.0006
473 NEOPLASM 7 0.0006
474 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
475 MENINGITIS 4 0.0006
476 ANXIETY DISORDER 2 0.0006
477 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
478 HEMIPARESIS 10 0.0006
479 HEPATIC CYST 2 0.0006
480 TRISMUS 3 0.0006
481 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
482 CHOLESTASIS 11 0.0006
483 URINE OUTPUT DECREASED 5 0.0006
484 HYPERKALAEMIA 20 0.0006
485 NECROTISING FASCIITIS 2 0.0006
486 LUNG INFILTRATION 5 0.0006
487 FACIAL PARESIS 2 0.0006
488 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
489 HAEMORRHAGIC DIATHESIS 2 0.0006
490 HAEMOLYTIC ANAEMIA 5 0.0006
491 PYODERMA GANGRENOSUM 2 0.0006
492 BRAIN OEDEMA 7 0.0006
493 CARDIOVASCULAR DISORDER 14 0.0006
494 SCLERODERMA 2 0.0005
495 MELAENA 12 0.0005
496 UROSEPSIS 5 0.0005
497 HYPOPHOSPHATAEMIA 4 0.0005
498 ARTERIOSCLEROSIS 5 0.0005
499 HEPATIC NECROSIS 2 0.0005
500 APHASIA 16 0.0005
501 PANCREATITIS 28 0.0005
502 CHOLECYSTITIS ACUTE 3 0.0005
503 CLAVICLE FRACTURE 2 0.0005
504 PYREXIA 180 0.0005
505 ENTEROCOLITIS 3 0.0005
506 NERVOUS SYSTEM DISORDER 16 0.0005
507 NAIL DISCOLOURATION 2 0.0005
508 BODY TEMPERATURE DECREASED 5 0.0005
509 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
510 PLEURISY 3 0.0005
511 ODYNOPHAGIA 3 0.0005
512 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
513 LYMPHOPENIA 7 0.0005
514 CEREBRAL INFARCTION 12 0.0005
515 SUBARACHNOID HAEMORRHAGE 5 0.0005
516 RECURRENT CANCER 2 0.0005
517 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
518 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
519 SOCIAL PROBLEM 2 0.0005
520 DIARRHOEA 311 0.0005
521 HEMIPLEGIA 4 0.0005
522 LYMPHADENOPATHY 17 0.0005
523 THERAPEUTIC RESPONSE DECREASED 29 0.0005
524 ABDOMINAL PAIN 111 0.0005
525 LIVER DISORDER 21 0.0005
526 PURULENT DISCHARGE 2 0.0005
527 PSEUDOMONAS INFECTION 4 0.0005
528 PANCYTOPENIA 26 0.0005
529 HEPATITIS ACUTE 3 0.0005
530 MONOPLEGIA 2 0.0005
531 NODULE 6 0.0005
532 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
533 WOUND INFECTION 5 0.0005
534 BLOOD CREATINE INCREASED 2 0.0005
535 ENCEPHALOPATHY 11 0.0004
536 SKIN INFECTION 5 0.0004
537 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
538 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
539 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
540 DISEASE RECURRENCE 21 0.0004
541 HIDRADENITIS 4 0.0004
542 ABDOMINAL HERNIA 2 0.0004
543 RENAL FAILURE 58 0.0004
544 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
545 OVARIAN CANCER 4 0.0004
546 HYPOKALAEMIA 20 0.0004
547 RENAL FUNCTION TEST ABNORMAL 2 0.0004
548 GASTRITIS EROSIVE 2 0.0004
549 DYSPNOEA EXERTIONAL 16 0.0004
550 ACUTE KIDNEY INJURY 65 0.0004
551 RENAL FAILURE ACUTE 18 0.0004
552 THERAPY NON-RESPONDER 19 0.0004
553 SINUS TACHYCARDIA 6 0.0004
554 LEUKOPENIA 21 0.0004
555 CEREBRAL HAEMORRHAGE 15 0.0004
556 POLYNEUROPATHY 5 0.0004
557 HYPOVOLAEMIC SHOCK 2 0.0004
558 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
559 APHAGIA 2 0.0004
560 FAECES SOFT 3 0.0004
561 CIRCULATORY COLLAPSE 7 0.0004
562 CYTOPENIA 5 0.0004
563 LUNG DISORDER 20 0.0004
564 HEPATOMEGALY 4 0.0004
565 ACUTE MYOCARDIAL INFARCTION 12 0.0004
566 MUCOUS STOOLS 2 0.0004
567 SEPSIS 45 0.0004
568 HYPERNATRAEMIA 2 0.0004
569 FLUID INTAKE REDUCED 2 0.0004
570 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
571 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
572 ERYSIPELAS 2 0.0004
573 ISCHAEMIC STROKE 7 0.0004
574 PHLEBITIS 2 0.0004
575 DYSGEUSIA 29 0.0004
576 THYROID DISORDER 6 0.0004
577 CACHEXIA 2 0.0004
578 CEREBRAL ISCHAEMIA 2 0.0004
579 ATRIOVENTRICULAR BLOCK 3 0.0004
580 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
581 VOMITING 182 0.0004
582 FAILURE TO THRIVE 2 0.0004
583 VENTRICULAR EXTRASYSTOLES 4 0.0004
584 ACUTE MYELOID LEUKAEMIA 6 0.0004
585 C-REACTIVE PROTEIN INCREASED 14 0.0004
586 DERMATITIS 8 0.0004
587 DYSURIA 14 0.0004
588 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 27 0.0004
589 CARDIAC ARREST 31 0.0004
590 EYE HAEMORRHAGE 5 0.0004
591 UTERINE CANCER 3 0.0004
592 ANAL FISSURE 2 0.0004
593 RENAL INJURY 11 0.0004
594 BLOOD POTASSIUM INCREASED 6 0.0004
595 SHOCK HAEMORRHAGIC 3 0.0004
596 DECUBITUS ULCER 3 0.0004
597 NEUTROPHIL COUNT DECREASED 15 0.0004
598 ACUTE HEPATIC FAILURE 5 0.0004
599 HICCUPS 3 0.0004
600 IMPAIRED HEALING 12 0.0004
601 VENTRICULAR TACHYCARDIA 6 0.0004
602 SPINAL COMPRESSION FRACTURE 3 0.0004
603 MUSCULOSKELETAL PAIN 19 0.0004
604 DEATH 312 0.0004
605 VENTRICULAR FIBRILLATION 4 0.0004
606 SKIN DISORDER 12 0.0004
607 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
608 INTRACRANIAL PRESSURE INCREASED 2 0.0004
609 DRUG EFFECT INCOMPLETE 13 0.0004
610 MALNUTRITION 4 0.0004
611 ORAL PAIN 8 0.0004
612 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
613 ACUTE PULMONARY OEDEMA 2 0.0004
614 NEPHROPATHY TOXIC 4 0.0004
615 FISTULA 4 0.0004
616 BLOOD CALCIUM DECREASED 4 0.0004
617 MYOCARDIAL ISCHAEMIA 4 0.0004
618 INTERSTITIAL LUNG DISEASE 17 0.0004
619 ASTHENIA 132 0.0004
620 FATIGUE 273 0.0004
621 CYTOKINE RELEASE SYNDROME 7 0.0003
622 EPISTAXIS 26 0.0003
623 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
624 MYELODYSPLASTIC SYNDROME 5 0.0003
625 METABOLIC DISORDER 2 0.0003
626 NEUROTOXICITY 6 0.0003
627 GASTRITIS 9 0.0003
628 SPINAL OSTEOARTHRITIS 3 0.0003
629 HAEMOGLOBIN DECREASED 35 0.0003
630 HYPOXIA 12 0.0003
631 PURPURA 3 0.0003
632 PERITONITIS 7 0.0003
633 ATAXIA 4 0.0003
634 PULMONARY OEDEMA 15 0.0003
635 LETHARGY 19 0.0003
636 BONE DISORDER 6 0.0003
637 NO THERAPEUTIC RESPONSE 4 0.0003
638 GRAND MAL CONVULSION 3 0.0003
639 DEVICE RELATED INFECTION 5 0.0003
640 HEPATIC ENCEPHALOPATHY 3 0.0003
641 BLOOD PRESSURE INCREASED 49 0.0003
642 ATRIAL FIBRILLATION 31 0.0003
643 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
644 ULCER 5 0.0003
645 ANGINA PECTORIS 9 0.0003
646 HYPOPHAGIA 8 0.0003
647 ATELECTASIS 3 0.0003
648 SINUS BRADYCARDIA 3 0.0003
649 HYPOGLYCAEMIA 15 0.0003
650 INJECTION SITE INDURATION 4 0.0003
651 TOXICITY TO VARIOUS AGENTS 52 0.0003
652 VITREOUS FLOATERS 3 0.0003
653 THERAPY CHANGE 3 0.0003
654 ORAL CANDIDIASIS 4 0.0003
655 HOSPICE CARE 3 0.0003
656 APPETITE DISORDER 2 0.0003
657 SYNCOPE 30 0.0003
658 URINARY RETENTION 10 0.0003
659 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
660 DYSPNOEA 168 0.0003
661 FACE OEDEMA 5 0.0003
662 POSTOPERATIVE WOUND INFECTION 2 0.0003
663 TACHYPNOEA 4 0.0003
664 PALLOR 8 0.0003
665 NEUTROPHIL COUNT INCREASED 3 0.0003
666 INTESTINAL OBSTRUCTION 11 0.0003
667 ECCHYMOSIS 2 0.0003
668 RESPIRATORY DISTRESS 8 0.0003
669 ENCEPHALITIS 2 0.0003
670 AUTOIMMUNE HEPATITIS 2 0.0003
671 PETECHIAE 3 0.0003
672 EXTRASYSTOLES 2 0.0003
673 MASS 4 0.0003
674 FOLLICULITIS 3 0.0003
675 EOSINOPHILIA 5 0.0003
676 BLOOD TEST ABNORMAL 4 0.0003
677 INFECTION 41 0.0003
678 NAUSEA 224 0.0003
679 RENAL PAIN 3 0.0003
680 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
681 PULMONARY TOXICITY 2 0.0003
682 DRUG ERUPTION 5 0.0003
683 RETINAL HAEMORRHAGE 2 0.0003
684 AGEUSIA 7 0.0003
685 PNEUMONIA 90 0.0003
686 DEEP VEIN THROMBOSIS 18 0.0003
687 SEPTIC SHOCK 12 0.0003
688 OESOPHAGITIS 3 0.0003
689 ARRHYTHMIA 13 0.0003
690 BONE PAIN 16 0.0003
691 RENAL CANCER 13 0.0003
692 BLINDNESS TRANSIENT 2 0.0003
693 HAEMATOMA 7 0.0003
694 TACHYCARDIA 24 0.0003
695 RASH MACULO-PAPULAR 6 0.0003
696 HEPATIC STEATOSIS 5 0.0003
697 PAROSMIA 2 0.0003
698 PEMPHIGOID 2 0.0003
699 GASTRIC ULCER 5 0.0003
700 GASTRIC HAEMORRHAGE 3 0.0003
701 RENAL FAILURE CHRONIC 2 0.0003
702 FREQUENT BOWEL MOVEMENTS 7 0.0003
703 HAEMOLYSIS 2 0.0003
704 OEDEMA 14 0.0003
705 HAEMATOCRIT DECREASED 5 0.0003
706 BLOOD ALBUMIN DECREASED 2 0.0003
707 OFF LABEL USE 220 0.0003
708 HYPERLIPIDAEMIA 3 0.0003
709 WEIGHT DECREASED 70 0.0003
710 DRUG INTOLERANCE 24 0.0002
711 RHINITIS 2 0.0002
712 MUSCLE DISORDER 2 0.0002
713 OEDEMA PERIPHERAL 30 0.0002
714 POLYURIA 2 0.0002
715 ESCHERICHIA INFECTION 2 0.0002
716 PHOTOSENSITIVITY REACTION 4 0.0002
717 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
718 CHILLS 28 0.0002
719 PERICARDITIS 4 0.0002
720 HAEMATEMESIS 6 0.0002
721 HEPATIC CYTOLYSIS 3 0.0002
722 EATING DISORDER 5 0.0002
723 HYPOTENSION 47 0.0002
724 ANOREXIA 3 0.0002
725 RECTAL HAEMORRHAGE 10 0.0002
726 ANURIA 2 0.0002
727 ORTHOSTATIC HYPOTENSION 4 0.0002
728 LYMPHOCYTE COUNT DECREASED 4 0.0002
729 BRADYCARDIA 12 0.0002
730 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
731 CARDIAC FAILURE CONGESTIVE 18 0.0002
732 GASTROINTESTINAL DISORDER 20 0.0002
733 LOSS OF LIBIDO 2 0.0002
734 ANAL INCONTINENCE 2 0.0002
735 METABOLIC ACIDOSIS 7 0.0002
736 CELLULITIS 11 0.0002
737 DIVERTICULITIS 6 0.0002
738 HYPOMAGNESAEMIA 3 0.0002
739 PHOTOPHOBIA 4 0.0002
740 BLOOD SODIUM DECREASED 4 0.0002
741 CONFUSIONAL STATE 34 0.0002
742 PRODUCTIVE COUGH 10 0.0002
743 INCREASED APPETITE 4 0.0002
744 PULMONARY FIBROSIS 4 0.0002
745 NEURALGIA 5 0.0002
746 GASTROENTERITIS 3 0.0002
747 TREATMENT FAILURE 17 0.0002
748 DYSPHONIA 12 0.0002
749 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
750 RENAL TUBULAR NECROSIS 2 0.0002
751 URINARY INCONTINENCE 6 0.0002
752 ABASIA 5 0.0002
753 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
754 CONSTIPATION 44 0.0002
755 DRUG INEFFECTIVE 265 0.0002
756 HAEMORRHAGE 21 0.0002
757 BLOOD POTASSIUM DECREASED 6 0.0002
758 EMPHYSEMA 2 0.0002
759 EPILEPSY 6 0.0002
760 BODY TEMPERATURE INCREASED 4 0.0002
761 RIB FRACTURE 4 0.0002
762 MALAISE 85 0.0002
763 MUSCULAR WEAKNESS 22 0.0002
764 RASH GENERALISED 5 0.0002
765 CONVULSION 11 0.0002
766 INCONTINENCE 2 0.0002
767 RETCHING 4 0.0002
768 DECREASED ACTIVITY 2 0.0002
769 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
770 CHOLELITHIASIS 6 0.0002
771 ASPIRATION 2 0.0002
772 HAEMATOCHEZIA 10 0.0002
773 NERVE INJURY 2 0.0002
774 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
775 BLOOD UREA INCREASED 3 0.0002
776 CANDIDA INFECTION 3 0.0002
777 FLATULENCE 10 0.0002
778 SCAR 3 0.0002
779 RED BLOOD CELL COUNT DECREASED 5 0.0002
780 SHOCK 4 0.0002
781 POST PROCEDURAL HAEMORRHAGE 2 0.0002
782 HEART RATE DECREASED 6 0.0002
783 SPINAL PAIN 2 0.0002
784 ABDOMINAL PAIN UPPER 35 0.0002
785 LEUKOCYTOSIS 3 0.0002
786 HEPATITIS C 2 0.0002
787 PELVIC PAIN 3 0.0002
788 SEIZURE 19 0.0002
789 COUGH 46 0.0002
790 BACK PAIN 38 0.0002
791 CHEST PAIN 30 0.0002
792 GENERALISED OEDEMA 2 0.0002
793 PHARYNGITIS 2 0.0002
794 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
795 DERMATITIS ALLERGIC 2 0.0002
796 GASTRIC CANCER 4 0.0002
797 POST PROCEDURAL COMPLICATION 3 0.0002
798 ACUTE RESPIRATORY FAILURE 3 0.0002
799 HIATUS HERNIA 2 0.0002
800 DIPLOPIA 4 0.0002
801 RESPIRATORY TRACT INFECTION 4 0.0002
802 ABDOMINAL DISTENSION 16 0.0002
803 BLOOD PRESSURE ABNORMAL 3 0.0002
804 RENAL DISORDER 7 0.0002
805 THROMBOSIS 12 0.0001
806 QUALITY OF LIFE DECREASED 2 0.0001
807 LOSS OF CONSCIOUSNESS 19 0.0001
808 TASTE DISORDER 3 0.0001
809 URINARY TRACT INFECTION 25 0.0001
810 GINGIVAL BLEEDING 2 0.0001
811 DELIRIUM 5 0.0001
812 ORAL DISCOMFORT 2 0.0001
813 NECK PAIN 8 0.0001
814 ABDOMINAL DISCOMFORT 24 0.0001
815 MOUTH ULCERATION 3 0.0001
816 DEVICE OCCLUSION 2 0.0001
817 PARALYSIS 2 0.0001
818 CARDIOGENIC SHOCK 2 0.0001
819 IMPAIRED QUALITY OF LIFE 2 0.0001
820 CARDIAC DISORDER 13 0.0001
821 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
822 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
823 NEEDLE ISSUE 4 0.0001
824 CHEST DISCOMFORT 14 0.0001
825 PALPITATIONS 16 0.0001
826 NEOPLASM MALIGNANT 9 0.0001
827 GLOSSODYNIA 3 0.0001
828 DYSARTHRIA 5 0.0001
829 BLOOD COUNT ABNORMAL 2 0.0001
830 ILL-DEFINED DISORDER 8 0.0001
831 NEPHROLITHIASIS 6 0.0001
832 SKIN DISCOLOURATION 6 0.0001
833 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
834 LYMPHOMA 2 0.0001
835 MYALGIA 22 0.0001
836 RASH 56 0.0001
837 RASH ERYTHEMATOUS 6 0.0001
838 SCIATICA 2 0.0001
839 BLOOD PRESSURE FLUCTUATION 3 0.0001
840 SENSORY DISTURBANCE 2 0.0001
841 HEADACHE 78 0.0001
842 NIGHT SWEATS 4 0.0001
843 PRESYNCOPE 3 0.0001
844 AGITATION 9 0.0001
845 PRODUCT USE ISSUE 23 0.0001
846 MANIA 2 0.0001
847 DRUG LEVEL INCREASED 2 0.0001
848 COAGULOPATHY 2 0.0001
849 ABDOMINAL PAIN LOWER 3 0.0001
850 SKIN EXFOLIATION 10 0.0001
851 CHRONIC KIDNEY DISEASE 9 0.0001
852 OSTEOARTHRITIS 5 0.0001
853 METRORRHAGIA 2 0.0001
854 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
855 PAIN 71 0.0001
856 VAGINAL HAEMORRHAGE 5 0.0001
857 MYOCARDIAL INFARCTION 20 0.0001
858 RASH MACULAR 4 0.0001
859 COLD SWEAT 2 0.0001
860 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
861 OSTEOMYELITIS 2 0.0001
862 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
863 TREATMENT NONCOMPLIANCE 6 0.0001
864 END STAGE RENAL DISEASE 2 0.0001
865 SKIN LESION 3 0.0001
866 OROPHARYNGEAL PAIN 10 0.0001
867 BLISTER 6 0.0001
868 PAIN IN JAW 3 0.0001
869 DYSPHAGIA 10 0.0001
870 BLOOD URINE PRESENT 2 0.0001
871 GLAUCOMA 2 0.0001
872 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
873 ORAL HERPES 2 0.0001
874 SKIN FISSURES 2 0.0001
875 PAIN IN EXTREMITY 30 0.0001
876 DISABILITY 2 0.0001
877 RESPIRATORY DISORDER 3 0.0001
878 CONDITION AGGRAVATED 30 0.0001
879 FEEDING DISORDER 2 0.0001
880 BLINDNESS 4 0.0001
881 THERAPY INTERRUPTED 7 0.0001
882 FEELING HOT 6 0.0001
883 PERIPHERAL SWELLING 15 0.0001
884 INFLAMMATION 5 0.0001
885 CARDIO-RESPIRATORY ARREST 4 0.0001
886 NEUROPATHY PERIPHERAL 9 0.0001
887 MOVEMENT DISORDER 3 0.0001
888 RHINORRHOEA 6 0.0001
889 LACTIC ACIDOSIS 3 0.0001
890 FAECES DISCOLOURED 2 0.0001
891 PRODUCT PRESCRIBING ISSUE 2 0.0001
892 ALOPECIA 18 0.0001
893 OSTEONECROSIS 3 0.0001
894 ANGIOEDEMA 4 0.0001
895 VISUAL ACUITY REDUCED 3 0.0001
896 DIZZINESS 45 0.0001
897 VIRAL INFECTION 3 0.0001
898 ADVERSE DRUG REACTION 8 0.0001
899 HEART RATE IRREGULAR 2 0.0001
900 ERYTHEMA 18 0.0001
901 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
902 HYPERSENSITIVITY 16 0.0001
903 COMA 4 0.0001
904 HEPATIC CANCER 2 0.0001
905 PARAESTHESIA 13 0.0001
906 VERTIGO 5 0.0001
907 ARTHRALGIA 34 0.0001
908 DYSPEPSIA 8 0.0001
909 DIABETES MELLITUS 6 0.0001
910 FLUID RETENTION 4 0.0001
911 THERAPY CESSATION 4 0.0001
912 AMNESIA 5 0.0001
913 CEREBROVASCULAR ACCIDENT 13 0.0001
914 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
915 ECZEMA 4 0.0001
916 DISORIENTATION 3 0.0001
917 DRY SKIN 10 0.0001
918 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
919 PAIN OF SKIN 2 0.0001
920 DISTURBANCE IN ATTENTION 4 0.0001
921 CONTUSION 7 0.0001
922 VISUAL IMPAIRMENT 9 0.0001
923 POLLAKIURIA 3 0.0001
924 OXYGEN SATURATION DECREASED 4 0.0001
925 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
926 HYPERSOMNIA 2 0.0001
927 HERPES ZOSTER 4 0.0001
928 MOBILITY DECREASED 5 0.0001
929 DYSSTASIA 2 0.0001
930 HALLUCINATION 5 0.0001
931 HOT FLUSH 5 0.0001
932 CORONARY ARTERY DISEASE 2 0.0001
933 BLOOD CHOLESTEROL INCREASED 3 0.0001
934 CYSTITIS 2 0.0001
935 HYPERHIDROSIS 8 0.0001
936 DEPRESSION 14 0.0001
937 BLOOD PRESSURE DECREASED 4 0.0001
938 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
939 FLUSHING 6 0.0001
940 VISION BLURRED 8 0.0001
941 GAIT DISTURBANCE 11 0.0001
942 SPEECH DISORDER 3 0.0001
943 RASH PRURITIC 3 0.0001
944 ACCIDENTAL OVERDOSE 2 0.0001
945 ADVERSE EVENT 5 0.0001
946 INJECTION SITE MASS 2 0.0001
947 BRONCHITIS 4 0.0001
948 MEDICATION ERROR 3 0.0001
949 INFLUENZA 6 0.0001
950 SWELLING 5 0.0001
951 INJECTION SITE SWELLING 4 0.0001
952 MEMORY IMPAIRMENT 7 0.0001
953 ABNORMAL BEHAVIOUR 2 0.0001
954 HEART RATE INCREASED 5 0.0001
955 CATARACT 3 0.0001
956 JOINT SWELLING 6 0.0000
957 DRY MOUTH 4 0.0000
958 INFLUENZA LIKE ILLNESS 4 0.0000
959 PRURITUS 18 0.0000
960 HYPOACUSIS 2 0.0000
961 INTENTIONAL PRODUCT MISUSE 4 0.0000
962 INFUSION RELATED REACTION 3 0.0000
963 SOMNOLENCE 9 0.0000
964 COGNITIVE DISORDER 2 0.0000
965 TREMOR 7 0.0000
966 INSOMNIA 11 0.0000
967 HYPOAESTHESIA 6 0.0000
968 DRY EYE 2 0.0000
969 UNEVALUABLE EVENT 3 0.0000
970 ACNE 3 0.0000
971 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
972 ANXIETY 11 0.0000
973 MUSCLE SPASMS 7 0.0000
974 ARTHRITIS 3 0.0000
975 DEPRESSED MOOD 2 0.0000
976 PROSTATE CANCER 3 0.0000
977 FALL 12 0.0000
978 EYE PAIN 2 0.0000
979 COVID-19 6 0.0000
980 BLADDER CANCER 2 0.0000
981 DISCOMFORT 2 0.0000
982 HOSPITALISATION 5 0.0000
983 INJURY 2 0.0000
984 SLEEP DISORDER 2 0.0000
985 WEIGHT INCREASED 6 0.0000
986 ASTHMA 3 0.0000
987 BLOOD GLUCOSE INCREASED 5 0.0000
988 URTICARIA 4 0.0000
989 MIGRAINE 2 0.0000
990 SINUSITIS 2 0.0000
991 OVERDOSE 4 0.0000
992 FEELING ABNORMAL 4 0.0000
993 INJECTION SITE PAIN 2 0.0000